The Bridgewater-based company says the deal expands its commercial institutional and specialty portfolio in neurology, and adds commercial infrastructure in advance of its entry into the biosimilar institutional market.
Read More »
Patrick Fabbio joins the Newark-based pharmaceutical holding company with more than 25 years of financial, operational and transactional leadership experience.
Read More »
Nelson Ambrogio and John Berrios will serve on the U.S. Pharmaceutical Leadership Team and report directly to the sector's Americas Region President Sebastian Guth.
Read More »
© 2022 BridgeTower Media. All information on this site is copyrighted by BridgeTower Media.
All images are the sole property of BridgeTower Media and no rights are granted for any use without the express written consent of BridgeTower Media.